ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Boston Scientific (NYSE:BSX) will acquire Nalu Medical for $533M in cash for the equity it does not already own. Nalu specializes in peripheral nerve stimulation devices for treating chronic pain in ...
Medical Device Network on MSN
Boston Scientific acquires Nalu Medical for $533m
Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for ...
Prioritizing the location of novel biomarkers within the brain from methods of targeted stimulation is key to addressing ...
Christopher Maher holds a research fellowship funded by the National Health and Medical Research Council. Caitlin Jones does not work for, consult, own shares in or receive funding from any company or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback